Veozah Liver Warning: What the FDA Boxed Warning Means and What to Do Next
The straight answer if you searched “Veozah liver warning”:
In December 2024, the FDA added a boxed warning — its single strongest warning — to Veozah (fezolinetant) for rare but serious liver injury. That sounds scary, and it’s real. But it does not mean Veozah was banned or recalled, and it does not mean everyone has to stop. For most women the risk is low — in approval studies, about 2.3% had a temporary bump in liver enzymes vs. 0.9% on a placebo, and there were no cases of severe liver injury.
The one rule that matters most: Stop Veozah immediately and get medical care — including liver blood tests — if you notice unusual tiredness, nausea, itching, yellow skin or eyes, dark urine, or pale-colored stools.
What actually changed is monitoring. You now need liver blood tests before you start and at set points through month 9. Whether to continue, switch, or stop is a decision to make with your clinician — not alone, and not based on a headline.
Disclosure:Built from FDA safety communications and the current Veozah prescribing information. We’re an independent comparison resource for HRT telehealth providers — not your doctor, and this isn’t medical advice. We may earn a commission if you book a visit through some links on this page.
Find your situation
| Your situation right now | The bottom line |
|---|---|
| Taking Veozah, feeling fine | Don’t panic. Check whether your month 1, 2, 3, 6, or 9 blood test is due. |
| Taking Veozah with possible liver symptoms | The label says to stop now and get medical care, including liver blood tests. |
| About to start Veozah | Get your baseline liver blood tests done and reviewed before your first pill. |
| You have cirrhosis, severe kidney disease, or take a CYP1A2 inhibitor | Veozah may not be safe for you. Ask your clinician or pharmacist before taking it. |
| Veozah just doesn’t feel right for you anymore | You have real options — non-hormone and hormone paths to weigh. If you’re not having warning symptoms, don’t switch or stop without a clinician’s plan. |
Build your Veozah lab calendar
Jump to the schedule section below — enter your start date and get every test date and a warning-signs checklist.
First, breathe: what does the Veozah liver warning actually mean?
The Veozah liver warning is an FDA boxed warning about a rare but serious risk of liver injury (hepatotoxicity — liver damage caused by a medicine). It was added in December 2024 after a real-world report of serious liver injury, and it now requires more frequent blood tests than many older websites still show.A boxed warning is the FDA’s most prominent warning — but it is not a recall, and it does not mean the drug is wrong for everyone.
Veozah (fezolinetant) is a non-hormone prescription pill for moderate-to-severe hot flashes and night sweats during menopause. It belongs to a class called NK3 receptor antagonists— it calms the part of your brain that controls body heat, without adding estrogen or any hormone. Many women choose it specifically because it’s hormone-free. Then they see “boxed warning” and “liver” and it feels like a betrayal. That reaction makes sense. But the warning is about a specific organ risk, not about hormones, and it comes with a clear plan to catch problems early.
What changed, and when
| Date | What happened |
|---|---|
| FDA approved Veozah for moderate-to-severe menopausal hot flashes. | |
| FDA warned that Veozah can cause rare but serious liver injury. | |
| FDA added a boxed warning — its strongest — and added more blood-test checkpoints. (FDA Drug Safety Communication) | |
| The current prescribing information reflects the boxed warning and the updated testing schedule. |
Should you stop taking Veozah because of the warning?
Don’t stop or continue based on an article alone — the FDA’s instruction is conditional. If you have signs that suggest liver injury, stop Veozah right away and get medical care. If you feel fine and your blood tests are normal, the warning is a reason to keep up your monitoring, not an automatic reason to quit. Stopping suddenly without a plan can bring your hot flashes roaring back, so loop in your clinician either way.
No symptoms — take a breath
- Check if a blood test (month 1, 2, 3, 6, or 9) is due
- If you’ve missed a test, message your prescriber
- Keep watching for the symptoms listed below
Have symptoms — act now
⚠️ Stop Veozah and get medical care right away if you notice any of these:
This doesn’t prove Veozah caused it — but the label is clear: don’t wait and see.
If you’re weighing whether Veozah still fits, it can help to see how current HRT safety guidance has changed before that conversation — the picture isn’t what it was a few years ago.
Can Veozah cause liver damage, and how serious is the risk really?
Yes, it can — but in studies the signal was mild: liver-enzyme elevations above three times the normal limit happened in about 2.3% of women on Veozah versus 0.9% on placebo, with no cases of severe liver injury in the trial population. The boxed warning was driven by rare real-world reports after Veozah came into wide use — which is exactly why the FDA strengthened the warning and added testing instead of pulling the drug.
1. The trial evidence (mild)
- ~2.3% on Veozah had temporary liver-enzyme spikes (>3× normal) vs 0.9% on placebo
- Most had no symptoms — levels returned to normal
- No one developed severe liver injury in the pre-approval studies
2. The real-world evidence (rare, but serious)
- One confirmed case: liver clearly injured within ~40 days of starting; enzymes climbed to more than 10× normal
- After stopping: symptoms faded; liver values slowly returned to normal
- Context: 28,700 patients dispensed Veozah in a single month (May 2024) — serious cases represent a small fraction
Honest takeaway: This is a real but uncommon risk, and it’s a watchable one. Astellas (Veozah’s maker) has said the drug’s overall benefit-risk “has not changed and remains positive” — while urging patients and doctors to follow the lab-testing plan. The FDA’s own message is that catching a problem early can keep it from getting worse — and may let the liver recover. The blood tests are the safety net. Sources: FDA Drug Safety Communication; Veozah prescribing information; NIH LiverTox.
What liver tests do you need before and during Veozah?
The current label calls for liver blood tests before you start, then monthly for the first three months, then again at months 6 and 9. The baseline test checks ALT, AST, ALP, and bilirubin. That’s six checkpoints in your first year.The calendar below is the working schedule — not a diagnosis, just the FDA’s recommended timeline.
| Checkpoint | When | Why it matters |
|---|---|---|
| Baseline | Before your first pill | Decides whether it’s safe to start at all |
| Month 1 | ~1 month in | Early safety check |
| Month 2 | ~2 months in | Covers the higher-risk early window |
| Month 3 | ~3 months in | Finishes the monthly stretch |
| Month 6 | ~6 months in | Later safety check |
| Month 9 | ~9 months in | Later safety check |
| Total, year 1 | 6 blood draws | |
What the tests actually measure (plain words):
- ALT and AST
- Liver enzymes. When liver cells are stressed, these leak into the blood — higher numbers can be a warning sign.
- ALP (alkaline phosphatase)
- Another enzyme that can rise with certain liver or bile problems.
- Bilirubin
- A yellow substance your liver clears out. When it builds up, you get jaundice (yellow skin and eyes).
- ULN (upper limit of normal)
- The top of the “normal” range for your specific lab. The cutoffs below are written as multiples of your lab’s ULN.
What not to do:
- Don’t skip a test because you feel fine — early liver changes often have no symptoms.
- Don’t try to read abnormal results alone.
- Don’t assume an old blood test from last year counts as your baseline.
- Don’t trust older websites that list only “3, 6, and 9 months.” The current label adds monthly testing for the first three months on top of that — a real difference.
See your exact test dates
Use the schedule above: baseline before day 1, then at 1 month, 2 months, 3 months, 6 months, and 9 months. Bring the schedule to your clinician and confirm who orders each test — your prescriber, your primary doctor, or your telehealth provider.
What lab numbers change the Veozah decision?
The label gives hard cutoffs. Use them to ask sharper questions, not to diagnose yourself. Reading your actual numbers is your prescriber’s job. Source: Veozah prescribing information.
When the label says “don’t start”
| Lab result | Meaning |
|---|---|
| ALT ≥ 2× ULN | Don’t start |
| AST ≥ 2× ULN | Don’t start |
| Total bilirubin ≥ 2× ULN | Don’t start |
When the label says “stop”
| Lab result during treatment | Meaning |
|---|---|
| ALT/AST > 5× ULN | Stop Veozah |
| ALT/AST > 3× ULN and bilirubin > 2× ULN | Stop Veozah |
| ALT/AST > 3× ULN (bilirubin normal) | Test more often until it resolves |
When you open your lab portal and see a number, it can look alarming on its own. These cutoffs are exactly why you bring the result to your prescriber instead of panicking — many small bumps resolve on their own with closer monitoring.
Who should not take Veozah?
Veozah is contraindicated (a medical “do not use”) if you have known cirrhosis, severe kidney problems or kidney failure, or if you take a CYP1A2 inhibitor — a medicine that slows how your body clears Veozah and pushes its levels up.
| Factor | Why it matters |
|---|---|
| Known cirrhosis (serious liver scarring) | Veozah is contraindicated |
| Severe kidney problems or kidney failure | Veozah is contraindicated |
| Taking a CYP1A2 inhibitor | Veozah is contraindicated — these raise Veozah levels in your body |
CYP1A2 inhibitors — the sneaky one
A few examples from the drug’s interaction information: fluvoxamine (an antidepressant), cimetidine (a heartburn medicine), and mexiletine (a heart-rhythm medicine). But this is not a complete list. Some everyday medicines and supplements can affect the same liver pathway.
Don’t try to clear yourself by scanning a short list. Hand your pharmacist your full lineup — every prescription, every OTC pill, every supplement — and let them check it. It takes two minutes.
What are the alternatives if Veozah isn’t your fit?
One of them, the newer non-hormone drug Lynkuet (elinzanetant), does not carry Veozah’s boxed liver warning — though it still has a liver-enzyme warning and needs baseline and 3-month liver tests. Other routes include SSRI/SNRI medicines, gabapentin, and hormone therapy for women who are candidates. The best choice depends on whyVeozah isn’t working for you.
| Option | Hormone? | FDA-approved for hot flashes? | Liver boxed warning? | Liver testing | Worth asking about if… |
|---|---|---|---|---|---|
| Veozah (fezolinetant) | No | Yes (2023) | Yes ⚠️ | Baseline, months 1–3, 6, 9 | You want non-hormone relief and can keep up the testing |
| Lynkuet (elinzanetant) | No | Yes (Oct 2025) | No * | Baseline + 3 months | You want a non-hormone option with lighter liver monitoring, and your clinician agrees it fits |
| Brisdelle (paroxetine 7.5 mg) | No | Yes — the only FDA-approved non-hormone SSRI for hot flashes | No | No Veozah-like schedule | A low-dose antidepressant fits your situation |
| Venlafaxine (off-label) | No | Off-label | No | No Veozah-like schedule | You want a low-cost, widely used option |
| Gabapentin (off-label) | No | Off-label | No | No Veozah-like schedule | Night sweats and sleep are your biggest problem |
| Oxybutynin (off-label) | No | Off-label | No | No Veozah-like schedule | Your clinician thinks it’s a good fit for you |
| Hormone therapy (HRT) | Yes | Yes | No | No Veozah-like schedule | You’re a candidate and want the most effective option for hot flashes |
* Lynkuet does not carry Veozah’s boxed hepatotoxicity warning, but its label still includes a liver-enzyme (transaminase) warning and requires the baseline and 3-month tests listed above. Always check each drug’s own cautions with your clinician. Sources: NIH LiverTox (elinzanetant).
Lynkuet — the closest non-hormone swap
If your only reason for leaving Veozah is the boxed liver warning, this is the one to ask about. Lynkuet (elinzanetant) was FDA-approved in October 2025. It works on the same brain heat-control system as Veozah, but blocks two receptors (NK1 and NK3) instead of one — and its label does not carry Veozah’s boxed hepatotoxicity warning. In 12-week studies, liver-enzyme elevations above three times normal happened in about 0.6% of women on Lynkuet vs 0.4% on placebo, the changes were temporary and caused no symptoms, and across 713 women in three trials there were no cases of liver injury with jaundice. See our full Veozah vs Lynkuet comparison.
- Still has a liver-enzyme warning and needs baseline + 3-month test
- Taken at bedtime; can cause next-day drowsiness (driving warning)
- Not for use in pregnancy; shouldn’t be combined with strong CYP3A4 inhibitors
- Very new — less long-term real-world data
- ~$625/month list price; insurance + savings cards can lower this significantly
Not sure which path fits you?
Take our free 60-second matching quiz and get a personalized plan you can bring to your clinician — including whether a hormone-free option like Lynkuet, an SSRI, or hormone therapy makes sense for your history.
Get your personalized menopause plan →How does Veozah compare with HRT after the 2024–2026 warning changes?
Here’s a twist almost no one sees coming: while the FDA was adding its strongest warning to Veozah — a non-hormone drug — for liver risk, it was busy removing boxed warnings from hormone therapy. On , the FDA approved labeling changes for six menopausal hormone products — Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva — removing boxed-warning language about heart disease, breast cancer, and dementia.
This does NOT mean hormones are automatically “safer” than Veozah
Removing those warnings does not make hormone therapy risk-free. The FDA and menopause experts still flag real concerns: blood clots, stroke, and gallbladder disease. And if you still have your uterus, you need a progestogen along with estrogen to protect the uterine lining. Hormone therapy also isn’t an option for everyone — a history of certain cancers, blood clots, or active liver disease can rule it out.
So the right framing isn’t “Veozah vs. HRT, pick the safe one.” It’s: these are different tools with different risk profiles, and the best fit depends on your body and history.
If you walked away from hormones years ago out of fear that’s since been revised, it’s worth a look at the latest HRT guidance and how to find a menopause provider that fits your history.
Does the warning make Veozah cost more?
The warning doesn’t set the drug’s price, but it can raise your real cost through required blood tests and follow-up. Veozah itself runs roughly $550 to $765 a month without insurance — with no generic available. Eligible patients with commercial insurance may pay $0 for the first month and as little as $30 per refill through the manufacturer’s savings card. See our full Veozah cost guide.
- No generic Veozah — cash prices stay high.
- The savings card works only with commercial insurance; not Medicare, Medicaid, or other government plans.
- Most commercial plans cover Veozah but often require prior authorization or step therapy.
- Don’t forget the six lab visits in year one — the cost depends on your insurance and lab.
- If cost is the sticking point: generic venlafaxine can run $10–$30/month; generic hormone therapy is also inexpensive for candidates.
What should you ask your prescriber before you start or continue Veozah?
The most useful questions are specific: ask what your baseline numbers were, when each follow-up test is due, whether any of your medicines are CYP1A2 inhibitors, and exactly which symptoms should make you stop and call.
A script you can read out loud if you’re nervous:
“I take Veozah, and I’m having [symptom]. I saw the boxed warning about liver injury. Do I need a liver blood test today, and should I stop until you tell me otherwise?”
The full question list (screenshot it or print it):
- What were my baseline ALT, AST, ALP, and bilirubin numbers?
- Were any of them close to the “don’t start” cutoff?
- What are my exact test dates for months 1, 2, 3, 6, and 9?
- Who orders the labs — your office, my primary doctor, or my telehealth provider?
- Which symptoms mean I should stop right away and call?
- Do any of my medicines or supplements count as CYP1A2 inhibitors?
- Does my liver or kidney history change the risk for me?
- If Veozah isn’t a good fit, what are my alternatives?
- What happens if my labs are a little high but I feel fine?
- Should I change my alcohol use or any other medicines that affect the liver?
Why we point people to Midi for Veozah monitoring
Most women don’t struggle with the questions; they struggle with the follow-through. Getting baseline labs ordered, finding a provider who does the monthly tests, and having someone review results on time is the real friction. Midi Healthhas clinicians who treat menopause specifically. Their care plans can include both hormone and non-hormone prescriptions, they send you to a local lab when testing is needed and review your results, and they’re in-network with most PPO insurance plans.
As of (from Midi’s own pages): Midi treats menopause and perimenopause with a dedicated clinician; its care plans can include hormone and non-hormone prescriptions; it orders local labs when testing is needed and reviews results; it’s in-network with most PPO plans (not enrolled with Medicaid/Medi-Cal; not covered by Medicare).
Honest trade-off: Midi is not the cheapest option if you’re fully out of pocket — flat-rate, cash-pay services like Alloy or Winona run lower per month. But if you want clinician-led care that bills your insurance and handles lab work as part of the visit, that trade favors Midi.
See if Midi takes your insurance and book a menopause visit →Affiliate link — it’s a medical visit, not a purchaseWhat other women worry about
“The liver stuff scares me.”
This is the big one, and it’s exactly why you’re here. The trial-versus-real-world breakdown above is the honest answer: uncommon, but serious enough to monitor.
“Is the monthly bloodwork at the start a pain?”
Honestly? It’s a real commitment — six lab visits in year one. For some women that’s no big deal; for others it’s the deciding factor. That’s a fair reason to consider Lynkuet (lighter testing) or another route.
“My enzymes went up, so I had to stop.”
It happens. And when it does, the standard pattern — like the FDA’s reported case — is that stopping reverses the changes. That’s the monitoring system working as designed.
Common forum themes — not medical evidence. The point isn’t to scare you or reassure you falsely — it’s to show you that your questions are the right questions.
Our bottom line on the Veozah liver warning
The right response isn’t panic, and it isn’t shrugging it off. The warning means Veozah needs proper screening before you start, blood tests on schedule, awareness of the symptoms that mean “stop and get care,” and a backup plan if the monitoring or the risk profile doesn’t fit your life. For the right person, with monitoring, it remains a legitimate non-hormone choice.
Veozah may still be a good fit if you:
- Have moderate-to-severe hot flashes or night sweats
- Want or need a non-hormone option
- Have no liver, kidney, or drug-interaction red flags
- Have acceptable baseline labs
- Can keep up the testing through month 9
- Understand the symptoms that mean stop and get care
Ask about a different path if you:
- Have cirrhosis, severe kidney disease, or take a CYP1A2 inhibitor
- Can’t realistically make it to the lab on schedule
- Have had unexplained liver-enzyme problems before
- Want a non-hormone option with lighter monitoring (ask about Lynkuet)
- Want a full menopause plan, not just a hot-flash pill
Whichever way you lean, the next move is the same: get the facts in front of a clinician who knows menopause, and decide together.
Veozah liver warning — frequently asked questions
- Does the Veozah liver warning mean the drug was recalled?
- No. The FDA’s warning and boxed warning do not mean Veozah was recalled. They mean the label was strengthened to highlight a rare but serious risk of liver injury and to require liver blood testing.
- Is the Veozah boxed warning the same as a black box warning?
- Yes. People often say “black box warning,” but the FDA’s current term is “boxed warning.” It is the FDA’s most prominent warning, and it was added to Veozah in December 2024 for rare but serious liver injury.
- How many liver tests do you need on Veozah?
- The current label calls for a test before you start, then monthly for the first three months, then again at months 6 and 9 — six checkpoints in your first year. Extra tests may be needed if you have symptoms or a high result.
- What liver symptoms should I watch for on Veozah?
- Watch for new or unusual tiredness, loss of appetite, nausea, vomiting, itching, yellow skin or eyes (jaundice), pale-colored stools, dark urine, or upper-right belly pain. If these appear, the label says to stop Veozah and get medical care, including liver blood tests.
- What if I missed one of my Veozah liver tests?
- Don’t guess or wait until the next checkpoint. Contact your prescriber and ask how to get back on the label schedule: baseline, monthly for the first three months, then months 6 and 9.
- Can I take Veozah if I have cirrhosis?
- No. The prescribing information lists known cirrhosis as a contraindication. Ask your clinician about other options rather than starting Veozah.
- Can I drink alcohol while taking Veozah?
- That’s a question for your clinician, especially if you have any liver risk factors or abnormal labs. Don’t assume alcohol is fine just because it isn’t your main concern — both alcohol and Veozah put demands on the liver.
- Is Veozah safer than hormone therapy?
- Not as a blanket rule. Veozah is hormone-free and carries a liver boxed warning; hormone therapy uses hormones and carries its own risks, such as blood clots and stroke. The safer choice depends on your history, your symptoms, and what you can monitor. For candidates, hormone therapy is the most effective treatment for hot flashes.
- What’s the difference between Veozah and Lynkuet?
- Both are non-hormone pills for moderate-to-severe hot flashes that act on the brain’s heat-control system. The key difference for many people: Lynkuet does not carry a liver boxed warning and needs lighter liver testing (baseline plus 3 months), while Veozah requires baseline plus monthly tests for three months and again at months 6 and 9. Lynkuet is newer, taken at bedtime, and can cause drowsiness.
- What if my Veozah liver enzymes are high but I feel fine?
- Don’t interpret the result alone. The label has specific cutoffs for stopping and for testing more often, so contact your prescriber and ask how your ALT, AST, ALP, and bilirubin compare with your lab’s upper limit of normal.
What we actually verified
Last verified:
| Type of claim | What we based it on |
|---|---|
| The warning, test schedule, and cutoffs | FDA label and FDA safety communication |
| Side effects and contraindications | The prescribing information |
| Alternatives and their liver monitoring | FDA labels, NIH LiverTox, and medical-society guidance |
| What other patients worry about | Common forum themes — not medical evidence |
| “Worth asking about” judgments | Clearly labeled as our editorial read |
Sources
- U.S. FDA — Drug Safety Communication: FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) (December 2024)
- Veozah (fezolinetant) Prescribing Information including Boxed Warning — Astellas
- NIH LiverTox — Fezolinetant (clinical-trial liver-enzyme data; contraindications)
- NIH LiverTox — Elinzanetant (Lynkuet; trial liver-enzyme data; monitoring), updated December 2025
- FDA — FDA approves labeling changes to menopausal hormone therapy products (February 12, 2026)
- Brisdelle (paroxetine) Prescribing Information (tamoxifen interaction)
- North American Menopause Society — 2023 Nonhormone Therapy Position Statement
- GoodRx — Veozah pricing and savings (checked June 2026)
Still not sure which menopause or HRT path is right for you?
Take our free 60-second matching quiz and get a personalized action plan you can bring to your next appointment — Veozah, Lynkuet, HRT, or something else.
Take the free 60-second matching quiz →Independent — not sponsored by any drug maker